Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
DNase I (RNase-free) for Reliable Cell Assays
2026-08-16
This scenario-driven guide explains how DNase I (RNase-free), SKU K1088, can improve DNA removal for RNA extraction, RT-PCR, in vitro transcription, and chromatin workflows that accompany cell viability, proliferation, and cytotoxicity studies. It also provides practical controls, optimization steps, and criteria for evaluating enzyme quality, cost-efficiency, and usability.
-
Puromycin Dihydrochloride in mRNA Assays
2026-08-15
Puromycin dihydrochloride is more than a routine selection reagent: it can help separate translation competence, cell survival, and delivery performance in advanced mRNA experiments. This article connects its ribosome-level mechanism with the localized p21 mRNA–LNP strategy reported for bladder cancer research.
-
Annexin V-FITC/PI Apoptosis Assay Kit Guide
2026-08-14
The Annexin V-FITC/PI Apoptosis Assay Kit provides a practical two-parameter method for separating viable, early apoptotic, and membrane-compromised cell populations by flow cytometry or fluorescence microscopy. It is intended for research use only; results should be validated for each cell type and should not be treated as diagnostic evidence or as proof of a specific death mechanism.
-
A Multimodal iPSC Platform for Cystic Fibrosis Drug Testing
2026-08-14
Berical and colleagues developed a patient-derived induced pluripotent stem cell platform that generates airway epithelial models from individuals with common and rare CFTR variants. By combining three-dimensional forskolin-induced spheroid swelling with polarized mucociliary airway cultures, the study detected genotype-specific baseline function and responses to CFTR modulators, creating a practical framework for rare-variant therapeutic research.
-
Y-27632 Dihydrochloride in Gut Neurobiology
2026-08-13
A translational framework for using Y-27632 dihydrochloride as both a cell-survival aid and a mechanistic ROCK perturbation in engineered gut neuro-epithelial models.
-
AZD1390: Selective ATM Kinase Inhibitor
2026-08-13
AZD1390 is a potent ATM kinase inhibitor for cancer research and DNA damage response studies. Product data report cellular ATM inhibition at 0.78 nM and radiosensitization activity in glioma and lung cancer models.
-
Live-Dead Cell Staining Kit for Scaffold Studies
2026-08-12
Use dual-fluorescence viability readouts to distinguish membrane-intact and membrane-compromised cells in drug, biomaterial, and hydrogel experiments. This workflow shows how Calcein-AM and PI staining can strengthen scaffold cytocompatibility testing while avoiding common imaging and flow-cytometry errors.
-
EPZ-6438: Mechanism and EZH2 Inhibitor Evidence
2026-08-12
EPZ-6438 is a selective EZH2 inhibitor that suppresses PRC2-dependent H3K27me3 formation. Its nanomolar biochemical activity, cancer-cell effects, and xenograft responses make it a useful tool for epigenetic cancer research.
-
Homer1a, Caspase-6, and Inflammatory Pain
2026-08-11
A 2025 rat study identifies a Homer1a–caspase-6–TNF-α axis in carrageenan-induced inflammatory pain. Pharmacological inhibition and Homer1a overexpression both reduced microglial activation, TNF-α signaling, and thermal hypersensitivity, positioning caspase-6 as a non-apoptotic inflammatory mediator in the spinal dorsal horn.
-
Nile Red for Reliable Lipid Droplet Assays
2026-08-11
Learn how Nile Red (SKU B8209) can clarify intracellular lipid droplet staining, distinguish membrane and droplet signals, and complement viability or cytotoxicity workflows. This scenario-based guide covers spectral selection, solvent compatibility, interpretation, and practical vendor evaluation.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-10
FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin reagent for visualizing α-D-glucose and α-D-mannose moieties on cell surfaces and tissue-associated glycoproteins or glycolipids. It is suited to immunofluorescence staining, fluorescence microscopy, and flow cytometry carbohydrate workflows, but not to non-carbohydrate targets or as a universal stain for all glycans.
-
Oltipraz Workflows for Nrf2 and MASLD Research
2026-08-09
Oltipraz provides a defined chemical tool for separating Nrf2-driven phase II enzyme induction from the multi-component effects of botanical interventions in liver research. This workflow connects GST and NQO1 assays with autophagy, ferroptosis, and MASLD readouts while emphasizing formulation control, flux measurements, and cautious interpretation.
-
G007-LK for Tankyrase and Wnt Research
2026-08-08
G007-LK is a selective tankyrase 1/2 inhibitor for connecting enzyme activity with Wnt/β-catenin, Hippo, and cancer-cell phenotypes. This workflow-focused guide covers concentration design, mechanistic readouts, colorectal and hepatocellular carcinoma applications, and troubleshooting.
-
(R)-MG132 as a Negative Control in Proteasome Assays
2026-08-07
(R)-MG132 is a functionally inactive MG-132 enantiomer designed to separate proteasome-dependent phenotypes from vehicle, stress, and off-target effects. This article presents practical workflows for using it in cell-based assays, ubiquitin-proteasome system research, and mechanistic studies of cancer metabolism.
-
Go 6983: Illuminating Human Blastoid Metabolism via PKC Inhi
2026-08-07
Explore Go 6983, a potent pan-PKC inhibitor, as a precision tool for dissecting PKC-driven metabolic regulation in human blastoid models. Discover how this approach advances PKC signaling pathway research and informs early embryonic lineage studies.